Cite
HARVARD Citation
Inoue, A. et al. (n.d.). Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702. Lung cancer. 89 (1), pp. 61-65. [Online].